1. Accelus, a minimally invasive spine device company, and CHP Merger Corp., a special purpose acquisition company, terminated a previously agreed-upon merger of the companies because of market conditions.
2. Seventeen spine devices received FDA approval in March. Read the full list here.
3. Carlsmed raised $30 million in series B funding to ramp up commercialization of its personalized spine implants.
4. SI-Bone’s iFuse Bedrock Granite spine implant received a CMS new technology add-on payment.
5. Johnson & Johnson saw first-quarter revenue rise 5 percent, with growth in its orthopedics sales.
6. AxioMed is progressing toward FDA approval for its viscoelastic for lumbar and cervical disc replacement.
7. ChoiceSpine launched its 3D-printed Harrier SA system for spinal fusion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
